Frontlight ResearchEarly access
Obesity trials in Romania
14 of 15 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Baia Mare, Brasov, Bucharest, Buzău, Jassi, Pitesti, Targu Mures, Târgu Mureş, Timisoara
- Age
- 18 years and over
- People
- 2,787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Brasov, Bucharest, Cluj-Napoca, Craiova, Jassi, Ploiesti, Timisoara
- Age
- 18 years and over
- People
- 1,600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - Phase 3Taking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Bacau, Bucharest, Constanța, Craiova, Timișoara
- Age
- 18 years to 70 years
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - Phase 3Taking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Bacau, Bucharest, Constanța, Craiova, Timișoara
- Age
- 18 years to 70 years
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - Phase 3Taking peopleA Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
- Where
- Brasov, Bucharest, Craiova, Oradea, Sibiu, Suceagu, Timisoara, Timișoara
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07202884 · EU 2025-522514-23-00 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- Brasov, Bucharest, Mangalia, Oradea, Satu Mare, Targoviste, Targu Mures, Timisoara
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - Phase 3Not yet taking people in RomaniaA Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Baia Mare, Brasov, Bucharest, Craiova, Galați, Mangalia, Oradea, Satu Mare
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00 - Phase 3Not yet taking people in RomaniaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Bacau, Baia Mare, Brasov, Bucharest, Craiova, Galati, Mangalia, Satu Mare, Targoviste
- Age
- 45 years to 64 years
- People
- 3,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Baia Mare, Brasov, Bucharest, Buzău, Iași, Piteşti, Târgu Mureş, Timisoara
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - Phase 1/2Taking peopleA Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
- Where
- Bucharest, Cluj-Napoca
- Age
- 18 years to 75 years
- People
- 400 worldwide
- Run by
- Wave Life Sciences USA, Inc.
See details and how to joinNCT06842186 · EU 2024-520203-41-00 - Phase 3Not yet taking people in RomaniaEfficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes
- Where
- Bacau, Baia Mare, Bucharest, Craiova, Galati, Iasi,, Jassi, Târgu Mureş, Timișoara
- Age
- 18 years and over
- People
- 3,000 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07896265 · EU 2025-524861-26-00 - Phase 3Taking peopleA Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Where
- Bucharest, Timisoara
- Age
- 8 years to 18 years
- People
- 460 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07253285 · EU 2023-509176-42-00 - Phase 3Active, not recruitingA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Baia Mare, Brasov, Bucharest, Buzău, Craiova, Oradea, Pitesti, Târgu Mureş, Timisoara
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - Phase 2CompletedEfficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
- Where
- Bucharest, Bucharest Sector 1
- Age
- 45 years and over
- People
- 600 worldwide
- Run by
- KeyBioscience AG
See details and how to joinNCT06833749 · EU 2024-517264-27-00